首页   按字顺浏览 期刊浏览 卷期浏览 Tubulointerstitial disease: role of ischemia and microvascular disease
Tubulointerstitial disease: role of ischemia and microvascular disease

 

作者: Takahiko Nakagawa,   Duk-Hee Kang,   Ryuji Ohashi,   Shin-ichi Suga,   Jaime Herrera-Acosta,   Bernardo Rodriguez-Iturbe,   Richard Johnson,  

 

期刊: Current Opinion in Nephrology and Hypertension  (OVID Available online 2003)
卷期: Volume 12, issue 3  

页码: 233-241

 

ISSN:1062-4821

 

年代: 2003

 

出版商: OVID

 

关键词: inflammation;angiogenesis;salt-sensitive

 

数据来源: OVID

 

摘要:

Purpose of reviewTubulointerstitial injury is characteristic of aging-associated renal injury and progressive renal disease. Salt-sensitive hypertension is also associated with tubulointerstitial inflammation, especially when accompanied by microvascular disease. Here we summarize recent studies on the pathogenesis and consequences of tubulointerstitial disease, emphasizing the role of ischemia and the microvasculature.Recent findingsTubulointerstitial injury occurs via several mechanisms of which one of the most important is chronic ischemia. Recent studies suggest that chronic vasoconstriction may contribute to the renal injury associated with angiotensin II, catecholamines, nitric oxide inhibition, hypokalemia, hyperuricemia, and cyclosporine nephropathy. Salt-sensitivity may result as a consequence of the tubulointerstitial inflammatory response to these conditions, and this appears to be perpetuated by the development of preglomerular vascular disease. With progression of tubulointerstitial disease there is also a loss of peritubular capillaries, and stimulating microvascular growth with angiogenic factors can stabilize renal function in these models.SummaryIschemia secondary to vasoconstriction or to structural changes of the renal vasculature may have important consequences both in terms of mediating salt-sensitive hypertension and renal progression. Angiogenic factors may have potential benefit in preventing or treating these conditions.

 

点击下载:  PDF (184KB)



返 回